Vericel sees FY25 revenue up 20%-23%

Sees FY25 gross margin 73%-74%. Sees FY25 adjusted EBITDA margin 25%-26%. “The Company executed extremely well in 2024, delivering high revenue growth across both franchises and very strong margin expansion and profitability,” said Nick Colangelo, president and CEO of Vericel (VCEL). “We are entering 2025 with a great deal of momentum and expect another year of high revenue growth, increasing utilization of MACI Arthro and significant growth in profitability and cash generation as we continue to progress toward our mid-term financial targets.”